
MRIguidance provides radiation-free, CT-like 3D bone images from standard MRI scans to improve diagnosis and surgical planning for hip and spine patients. The company achieves this with its BoneMRI software, which uses AI and deep learning to convert MRI data into volumetric bone visualizations compatible with all major MRI scanners and PACS. BoneMRI is offered as a SaaS subscription with cloud-enabled processing and integrations for clinical workflows, supporting orthopedics and radiology departments. The technology is positioned for clinical deployment following regulatory clearances and reimbursement coding. MRIguidance focuses on reducing ionizing radiation exposure while delivering richer diagnostic information from a single MRI exam.

MRIguidance provides radiation-free, CT-like 3D bone images from standard MRI scans to improve diagnosis and surgical planning for hip and spine patients. The company achieves this with its BoneMRI software, which uses AI and deep learning to convert MRI data into volumetric bone visualizations compatible with all major MRI scanners and PACS. BoneMRI is offered as a SaaS subscription with cloud-enabled processing and integrations for clinical workflows, supporting orthopedics and radiology departments. The technology is positioned for clinical deployment following regulatory clearances and reimbursement coding. MRIguidance focuses on reducing ionizing radiation exposure while delivering richer diagnostic information from a single MRI exam.
What they do: Convert standard MRI scans into CT-like 3D bone images using AI (BoneMRI)
Founded: 2016 (UMC Utrecht spin-off)
Headquarters: Utrecht, The Netherlands
Business model: SaaS subscription with cloud processing and PACS integrations
Regulatory status: Technology positioned for clinical deployment following regulatory clearances
Medical imaging for orthopedics and radiology focused on reducing ionizing radiation while improving bone visualization for diagnosis and surgical planning.
2016
Biotechnology
1.5 million
Seed investment for development and market roll-out
750,000
Best-in-Class selection bridge funding
$1.25M
Investment to support U.S. market roll-out
“EIT Health; Health Innovations; Mammoth Scientific / Mammoth Private Capital”